We publish what we are learning: about AI and quantum computing in life sciences, about the regulatory landscape, about where the technology is heading and where it falls short. Only when we have something worth saying.
We send one email per publication. No marketing. Unsubscribe anytime.
Each month we publish the one thing that most shapes where Burgeon Studio is heading. Choose a month to read it.
Our first product is soon to be deployed. Here is what it does, who it is for, what it does not claim, and how to ask for early access through the contact form.
The dermal fibroblast model is built on published measurements and is consistent with published observations. No dataset yet measures the inside of these spheroids directly. Here is how we say that plainly, and why it matters.
Every change to a spheroid normally means another culture of 7 to 14 days to see whether the centre survives. We explain why Spherix begins with the oxygen question, and what it takes to answer it on screen.
In March, Cleveland Clinic and IBM described a 303 atom miniprotein simulation on quantum hardware. In May the same partnership, joined by RIKEN, reported complexes about forty times larger. What improved, what did not, and who gets access.
An assessment of the current readiness of variational quantum algorithms for molecular simulation tasks relevant to regenerative medicine. What can be demonstrated today, what cannot, and where the research frontier is moving.
Burgeon Studio Insights is a publication for researchers, investors, and operators who want to understand where AI, and the quantum methods added only where AI is not enough, are going in life sciences, and why it matters now.
One email per publication. No noise. Unsubscribe at any time.